YU1.F Conavi Medical Corp.
- Market cap
- EUR 9.04M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is YU1.F undervalued?
Graham numberThe Graham number of Conavi Medical Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Conavi Medical Corp. fundamental analysis
No fundamental analysis for Conavi Medical Corp. yet.
Conavi Medical Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Conavi Medical Corp.
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
Full company profileConavi Medical Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Conavi Medical Corp. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|
| Income Statement | |||
| Revenue | 2.16M | 9.12M | 637K |
| Gross Profit | 53.0K | 7.63M | 637K |
| Operating Income | -26.2M | -14.9M | -21.5M |
| EBITDA | -34.6M | -8.02M | -16.3M |
| Net Income | -43.6M | -20.5M | -18.4M |
| EPS | -0.99 | -0.27 | -0.18 |
| Balance Sheet | |||
| Total Assets | 8.56M | 12.4M | 8.82M |
| Total Liabilities | 94.4M | 30.5M | 28.4M |
| Shareholders' Equity | -85.8M | -18.0M | -19.5M |
| Cash & Short-term Investments | 436K | 5.84M | 884K |
| Cash Flow | |||
| Operating Cash Flow | -20.1M | -25.1M | -18.2M |
| Capital Expenditure | 849K | 183K | 844K |
| Free Cash Flow | -21.0M | -25.3M | -19.1M |
| Ratios | |||
| ROA | -509.5% | -164.9% | -208.9% |
| Net Profit Margin | -2,018.3% | -224.9% | -2,891.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Conavi Medical Corp. dividends
Conavi Medical Corp. has not paid dividends in the last 2 fiscal years.
Who owns Conavi Medical Corp.
- Insiders 32.68%
- Institutions 0.00%
- Public & others 67.32%
- Shares outstanding 138M
- Free float 104M
Conavi Medical Corp. company profile
- Company name
- Conavi Medical Corp.
- Ticker
- YU1.F
- ISIN
- CA2059531020
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- September
- Address
- 293 Lesmill Road, Toronto, ON, Canada, M3B 2V1
- Website
- conavi.com/novasight
About Conavi Medical Corp.
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
Conavi Medical Corp. management
5- Mr. Thomas LoobyCEO & Director · born 1972
- Dr. Amandeep Singh ThindCo-Founder & CTO · born 1980
- Mr. Mark QuickChief Financial Officer
- John LefavourVice President of Operations
- Mr. Travis MoreVice President of Human Resources · born 1970